|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs and debt discount | |||||
| Loss (Gain) on debt extinguishment | |||||
| Interest rate swap termination | |||||
| Deferred income taxes | |||||
| Equity in earnings from unconsolidated entities | |||||
| Distributions of cumulative earnings from unconsolidated entities | |||||
| Cash paid for interest rate swap settlement | |||||
| Cash paid for interest rate cap | |||||
| Straight-line rental revenues | |||||
| Stock-based compensation | |||||
| Change in fair value of contingent consideration | |||||
| Goodwill impairment (Note 3) | |||||
| Gain on prepayment of settlement payable (Note 3) | |||||
| (Gain) Loss on asset disposals | |||||
| Gain on sale of operations | |||||
| Gain on sale of unconsolidated entity | |||||
| Accretion of settlement payable | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Other assets | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Settlement payable (Note 3) | |||||
| Net cash provided by operating activities | |||||
| Cash flow from investing activities | |||||
| Capital expenditures | |||||
| Asset acquisitions (Note 6) | |||||
| Proceeds from sale of equipment | |||||
| Proceeds from sale of operations | |||||
| Proceeds from sale of real estate, net of cash | |||||
| Proceeds from sale of unconsolidated entity | |||||
| Net cash used in investing activities | |||||
| Cash flow from financing activities | |||||
| Repayment of debt | |||||
| Proceeds from issuance of Notes | |||||
| Dividends paid | |||||
| Payments of settlement payable | |||||
| Payments of contingent consideration | |||||
| Borrowings under revolving credit facility | |||||
| Payments under revolving credit facility | |||||
| Proceeds from ABS Loan Facility | |||||
| Finance lease payments | |||||
| Payments for financing costs | |||||
| Payments for capped call option | |||||
| Payment for settlement of common stock warrant | |||||
| Proceeds from termination of bond hedge option | |||||
| Settlement Common Stock issuance (Note 20) | |||||
| Costs related to early repayment of debt | |||||
| Distributions paid to noncontrolling interest | |||||
| Payment for exchange of noncontrolling interest | |||||
| Proceeds from employee stock purchase plan | |||||
| Payments related to tax withholding for stock-based compensation | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net increase (decrease) in cash, restricted cash and cash equivalents | |||||
| Cash, restricted cash and cash equivalents at beginning of period | |||||
| Cash, restricted cash and cash equivalents at end of period | |||||
| Non-cash investing and financing activities: | |||||
| Property and equipment acquired but not yet paid | |||||
| Tenant capital improvements | |||||
| Receipt of equity method investment value in exchange for assets | |||||
| Sale of unconsolidated entity | |||||
Loading...